RecruitingNot ApplicableNCT06862180

Effect of Meal Replacement Therapy on Glucose Control and Metabolic Parameters in Patients With Uncontrolled Diabetes

The Effect of Meal Replacement Therapy on Glucose Control and Other Metabolic Parameters in Patients With Uncontrolled Type 2 Diabetes on Oral Hypoglycemic Agents: A Randomized Controlled Trial

Sponsor

Hospital Universiti Sains Malaysia

Enrollment

108 participants

Start Date

Nov 1, 2024

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 2

Summary

To evaluate the effect of meal replacement therapy on glucose control and other metabolic parameters in patients with uncontrolled type 2 diabetes. Methodology: This is an open-label, prospective, randomized control trial study. Study duration. August 2023 - March 2026. Study location. This study will be conducted at the Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia. Source Reference : People with type 2 diabetes mellitus attending the Hospital Universiti Sains Malaysia. Study source population : People with type 2 diabetes mellitus attended Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia during the study period.

Eligibility

Min Age: 30 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether using meal replacement products (special shakes or foods that replace regular meals) can help improve blood sugar control and other health measures in people with type 2 diabetes that is not well-controlled on their current medications. **You may be eligible if...** - You are between 30 and 65 years old - You have been diagnosed with type 2 diabetes - You are taking oral diabetes medications - Your HbA1c (a 3-month blood sugar average) is between 7% and 10% **You may NOT be eligible if...** - You have severe diabetes complications like end-stage kidney disease or advanced eye disease - You are pregnant or planning to become pregnant - You were diagnosed with diabetes less than 3 months ago - You are already on a weight loss program or currently using meal replacement products Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMeal replacement therapy

A serving of Contro Eazy Now is equivalent to 5 scoops (50g) contains 26.5g of carbohydrate, 10g of protein and 8.9g of fat. It supplies 215kcal of energy per serving